Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
- PMID: 40765425
- DOI: 10.1111/ddg.15838
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
Abstract
Background and objectives: Pemphigoid diseases are primarily mediated by IgG or IgA autoantibodies against the cutaneous basement membrane zone (BMZ). Although recent observations suggest the existence of exclusively IgM-mediated pemphigoid disease, a larger study is lacking.
Patients and methods: This prospective multicenter study included ten patients with exclusive IgM deposition along the BMZ by direct immunofluorescence (IF). Circulating IgM was detected by indirect IF and immunoblotting with recombinant BP180.
Results: The cohort, four females and six males with a median age of 77 years, presented predominantly with prurigo-like lesions without blisters and mucosal involvement. Sera from nine patients demonstrated linear IgM labeling the blister roof of human salt-split skin by indirect IF. Four patients yielded IgM reactivity against BP180, but none against BP230. In none of the controls (n = 100), anti-BMZ IgM was seen by direct IF. 1/30 and 3/60 controls with or without pruritic non-pemphigoid diseases revealed serum IgM reactivity against the BMZ, respectively.
Conclusions: IgM pemphigoid is characterized by exclusive tissue-bound anti-BMZ IgM, serum anti-BMZ IgM reactivity with BP180 as main target antigen, a predominantly non-bullous clinical phenotype, absence of mucosal involvement, and a rather mild disease course. Our findings indicate that IgM pemphigoid may represent a distinct entity.
Keywords: IgM; autoimmune bullous diseases; immunobullous diseases; pemphigoid.
© 2025 The Author(s). Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
References
REFERENCES
-
- Schmidt E, Zillikens D. Pemphigoid diseases. Lancet 2013; 381: 320‐332.
-
- Beek NV, Zillikens D, Schmidt E. Bullous Autoimmune Dermatoses. Dtsch Arztebl Int. 2021;118:413‐420.
-
- van Beek N, Holtsche MM, Atefi I, et al. State‐of‐the‐art diagnosis of autoimmune blistering diseases. Front Immunol. 2024;15:1363032.
-
- Amber KT, Murrell DF, Schmidt E, et al. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol 2018; 54: 26‐51.
-
- Velthuis PJ, de Jong MC, Kruis MH. Is there a linear IgM dermatosis? Significance of linear IgM junctional staining in cutaneous immunopathology. Acta Derm Venereol. 1988;68:8‐14.
LinkOut - more resources
Full Text Sources
Miscellaneous